Psychological Status and Related Factors of Thyroid Related Eye Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03426696|
Recruitment Status : Recruiting
First Posted : February 8, 2018
Last Update Posted : February 8, 2018
|Condition or disease||Intervention/treatment|
|Thyroid Related Eye Disease||Behavioral: psychological condition|
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Psychological Status and Related Factors of Thyroid Related Eye Disease|
|Actual Study Start Date :||December 1, 2017|
|Estimated Primary Completion Date :||December 1, 2018|
|Estimated Study Completion Date :||December 1, 2018|
Thyroid Related Eye Disease
Survey about the psychological condition would done with the patients of Thyroid Related Eye Disease
Behavioral: psychological condition
Graves ́ ophthalmopathy quality of life questionnaire, Symptom checklist 90(SLC-90), Hamilton anxiety scale(HAMA), Somatic self-rating scale(SSS), MATRICS Consensus Cognitive Battery (MCCB), Hamilton depression scale(HAMD)
- Quality of life questionnaire of patients of Thyroid Related Eye Disease [ Time Frame: immediately ]Graves ́ ophthalmopathy quality of life questionnaire (GO-QoL) , The GO-QoL contains 8 questions on visual functioning and 8 questions on appearance; answers on each subscale are transformed to scores ranging from 0 (worst) to 100 (best).
- Symptom checklist 90(SLC-90) [ Time Frame: immediately ]It consists of 90 items yielding nine scores along primary symptom dimensions and three scores among global distress indices. The primary symptom dimensions that are assessed are somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and a category of "additional items" which helps clinicians assess other aspect of the clients symptoms. Positive standard includes: total score 160 points or more, or positive items > 43 points, or any item > 2 points.
- Hamilton anxiety scale(HAMA) [ Time Frame: immediately ]This scale includes 14 items. All projects rated as: asymptomatic, light, medium, heavy, or very heavy. If the total score more than 29 points, there could be severe anxiety; more than 21 points, affirmation have obvious anxiety; more than 14 points, there must be some anxious; more than 7 points might be anxious; if less than 6 points, patients without anxiety symptoms.
- Somatic self-rating scale(SSS) [ Time Frame: immediately ]Somatic self-rating scale can let the doctor fully understand patients' mood and somatization symptoms. If the selected items scores more than 30 points, the patient may need to clinic treatment.
- Hamilton depression scale(HAMD) [ Time Frame: immediately ]It is the most common depression clinical application scale. Lower score presents lighter condition, and if the illness is heavier, the higher is the score. There is no depression symptoms for score less than eight points.
- Young manic rating scale(YMRS) [ Time Frame: immediately ]The Young Mania Rating Scale (YMRS) is a diagnostic questionnaire commonly used to evaluate manic symptoms in patients with bipolar 1 disorder and to assess treatment efficacy in clinical trials. This rating scale comprises eleven items (elevated mood, increased motor activity - energy, sexual interest, sleep, irritability, speech - rate and amount, language-thought disorder, content, disruptive-aggressive behavior, appearance, and insight). The total YMRS score is calculated as the summation of each of the eleven individual item scores.Lower score presents lighter condition, and if the illness is heavier, the higher is the score.There is no manic symptoms for score less than five points.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03426696
|Contact: Huijing Ye, Masteremail@example.com|
|Contact: Huasheng Yang, Doctorfirstname.lastname@example.org|
|Sun Yat-sen University||Recruiting|
|Guangzhou, Guangdong, China, 510000|
|Contact: Huijing Ye, Master 00862087331539 email@example.com|
|Contact: Huasheng Yang, Doctor 00862087331539 firstname.lastname@example.org|
|Principal Investigator:||Huijing Ye, Master||Sun Yat-sen University|